自拟芩连抗感胶囊治疗感冒250例临床观察  

Clinical Observation on QinLian KangGan Capsule in Treating Common Cold:a Report of 250 Cases

作　　者：赵明芳 李应宏 

机构地区：[1]甘肃省武威肿瘤医院,甘肃武威733000

出　　处：《西部中医药》2011年第11期70-72,共3页Western Journal of Traditional Chinese Medicine

摘　　要：目的:探讨自拟芩连抗感胶囊治疗感冒的临床疗效。方法:将500例感冒患者随机分为2组,每组250例,治疗组采用自拟芩连抗感胶囊治疗,对照组采用速效伤风胶囊治疗。7天后观察比较2组的有效率、治愈率及不良反应。结果:治疗组和对照组治疗2～3天的有效率分别为78.40%和60.00%,治疗组治愈率显著高于对照组(P<0.01);治疗5～7天的治愈率分别为94.00%和78.00%&,治疗组治愈率显著高于对照组(P<0.01)。对照组出现厌食3例、恶心2例、呕吐1例、皮疹1例;治疗组未见不良反应。结论:自拟芩连抗感胶囊治疗感冒疗效明显优于对照组,且无不良反应,值得临床推广应用。Objective：To explore the clinical effects of QinLian KangGan capsule in treating common cold. Method：All patients were randomly divided into two group：treatment group （250 cases） and control group（250 cases）. The treatment group was treated with QinLian KangGan capsule; and the control group were given quick resulted capsule for cold.All of the courses were 7 days.The effective rate, curative rate and adverse reaction were observed. Result：The effective rate of treatment group and control group are 78.40% and 60.00% respectively in 2-3 days.The cure rates of treatment group and control group are 94.00% and 78.00% respectively in 5-7 days.The rates effective and cure of treatment group are significantly higher than that of the control group （P〈0.01）.The control group appears 3 cases anorexia,2 cases nausea,1 case vomiting and 1 case skin rash.The treatment group did not appear adverse reaction.Conclusion：QinLian KangGan capsule in treating common cold could raise the cure rate and not appear adverse reaction. It can be applied to the clinic.

关 键 词：感冒 芩连抗感胶囊 治疗 临床研究性 

分 类 号：R254.1[医药卫生—中医内科学]